Propagenix

About:

Propagenix is focuses on development and commercialization of products to support applications in translational biomedical research.

Website: http://www.propagenix.com

Top Investors: Virginia Catalyst

Description:

Propagenix is a healthcare technology platform developer that aims to provide individualized diagnostics and cell therapies to improve human health. The company's systems are used in advanced therapies in development to differentiate primary epithelial adult stem cells for use in tissue models for drug discovery and toxicology screening, allowing medical professionals to address the acute shortage of transplantable organs that require mature, functional epithelial tissues such as skin, airways, and kidneys.

Total Funding Amount:

$9.23M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

2014-04-11

Founders:

Brian A. Pollok, Richard Schlegel, Sharon Challberg

Number of Employees:

1-10

Last Funding Date:

2017-06-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai